If dysregulated gene expression causes BC development in carriers bearing ATM mutations and contributes to the A-T phenotype, it is possible that ER inhibitors that prevent BC development and gene therapy to correct dysregulated gene expression could relieve the severe symptoms of cerebellar degeneration. This evidence concerns the gene ATM and cerebellar degeneration.